Indications & Usage Section
Menorrhagia Formulated for associated symptoms such as uterine fibroids, uterine polyps, endometriosis and other uterine and ovarian conditions.
The following Structured Product Label (SPL) was submitted to the FDA by Newton Laboratories, Inc. for the product Menorrhagia (NDC 55714-4521). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding indications & usage section, dosage & administration section, active ingredient section, purpose section, inactive ingredient section, questions section, warnings section, pregnancy or breast feeding section, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Menorrhagia Formulated for associated symptoms such as uterine fibroids, uterine polyps, endometriosis and other uterine and ovarian conditions.
Directions: Ages 12 and up, take 6 pellets orally one to four times daily or as directed by a healthcare professional.
Aletris 15x, Apocynum 15x, Cinchona 15x, Cinnamomum 15x, Conium 15x, Helonias dioica 15x, Lilium 15x, Millefolium 15x, Phosphorus 15x, Secale 15x, Thlaspi 15x, Trillium pendulum 15x, Apis mel. 3x, Hamamelis 3x, Hydrastis 3x.
Formulated for associated symptoms such as uterine fibroids, uterine polyps, endometriosis and other uterine and ovarian conditions.
Inactive Ingredients: Gluten-free, non-GMO, beet-derived sucrose pellets.
www.newtonlabs.net Newton Laboratories, Inc. FDA Est # 1051203 - Conyers, GA 30012
Questions? 1.800.448.7256
Warning: Do not use if tamper - evident seal is broken or missing. Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days. Keep out of reach of children.
Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days.
Keep out of reach of children.
* Please review the disclaimer below.